Carnival is a Buy and 2 More Analyst Notes to Read

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Biolase (NASDAQ:BIOL): Northland Capital reiterated its rating of Outperform for this company and changed its price target from $6 to $7.

Dow 15,000? S&P 1,600? Searching for market direction? Reduce the information clutter and uncover key insights and investment ideas. Click here to for Your Stock Investor Cheat Sheet Now!

BIOL

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business